Nonclassic congenital adrenal hyperplasia and the heterozygote carrier

Sara Ahmadi, Saadia Alvi, Randall Urban

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This article discusses the difficulty of differentiating three causes of adult androgen excess including nonclassic congenital adrenal hyperplasia caused by 21-hydroxylase deficiency, polycystic ovarian syndrome and heterozygote carrier of CYP21 mutations based on clinical findings. It also reviews the screening modalities that discriminate patients with nonclassic congenital adrenal hyperplasia and the heterozygote carrier of CYP21 mutations from the normal population. In addition, the current management of hyperandrogenism and ovulatory dysfunction in these patients is described.

Original languageEnglish (US)
Pages (from-to)239-246
Number of pages8
JournalExpert Review of Endocrinology and Metabolism
Volume8
Issue number3
DOIs
StatePublished - May 2013

Fingerprint

Congenital Adrenal Hyperplasia
Heterozygote
Hyperandrogenism
Mutation
Polycystic Ovary Syndrome
Androgens
Population
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency

Keywords

  • 21-hydroxylase deficiency
  • diagnosis
  • heterozygote carrier
  • hyperandrogenism
  • nonclassic congenital adrenal hyperplasia
  • treatment

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Nonclassic congenital adrenal hyperplasia and the heterozygote carrier. / Ahmadi, Sara; Alvi, Saadia; Urban, Randall.

In: Expert Review of Endocrinology and Metabolism, Vol. 8, No. 3, 05.2013, p. 239-246.

Research output: Contribution to journalArticle

@article{ff3f6b1f22294c18b3e980ea7636d254,
title = "Nonclassic congenital adrenal hyperplasia and the heterozygote carrier",
abstract = "This article discusses the difficulty of differentiating three causes of adult androgen excess including nonclassic congenital adrenal hyperplasia caused by 21-hydroxylase deficiency, polycystic ovarian syndrome and heterozygote carrier of CYP21 mutations based on clinical findings. It also reviews the screening modalities that discriminate patients with nonclassic congenital adrenal hyperplasia and the heterozygote carrier of CYP21 mutations from the normal population. In addition, the current management of hyperandrogenism and ovulatory dysfunction in these patients is described.",
keywords = "21-hydroxylase deficiency, diagnosis, heterozygote carrier, hyperandrogenism, nonclassic congenital adrenal hyperplasia, treatment",
author = "Sara Ahmadi and Saadia Alvi and Randall Urban",
year = "2013",
month = "5",
doi = "10.1586/eem.13.18",
language = "English (US)",
volume = "8",
pages = "239--246",
journal = "Expert Review of Endocrinology and Metabolism",
issn = "1744-6651",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Nonclassic congenital adrenal hyperplasia and the heterozygote carrier

AU - Ahmadi, Sara

AU - Alvi, Saadia

AU - Urban, Randall

PY - 2013/5

Y1 - 2013/5

N2 - This article discusses the difficulty of differentiating three causes of adult androgen excess including nonclassic congenital adrenal hyperplasia caused by 21-hydroxylase deficiency, polycystic ovarian syndrome and heterozygote carrier of CYP21 mutations based on clinical findings. It also reviews the screening modalities that discriminate patients with nonclassic congenital adrenal hyperplasia and the heterozygote carrier of CYP21 mutations from the normal population. In addition, the current management of hyperandrogenism and ovulatory dysfunction in these patients is described.

AB - This article discusses the difficulty of differentiating three causes of adult androgen excess including nonclassic congenital adrenal hyperplasia caused by 21-hydroxylase deficiency, polycystic ovarian syndrome and heterozygote carrier of CYP21 mutations based on clinical findings. It also reviews the screening modalities that discriminate patients with nonclassic congenital adrenal hyperplasia and the heterozygote carrier of CYP21 mutations from the normal population. In addition, the current management of hyperandrogenism and ovulatory dysfunction in these patients is described.

KW - 21-hydroxylase deficiency

KW - diagnosis

KW - heterozygote carrier

KW - hyperandrogenism

KW - nonclassic congenital adrenal hyperplasia

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=84876964317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876964317&partnerID=8YFLogxK

U2 - 10.1586/eem.13.18

DO - 10.1586/eem.13.18

M3 - Article

AN - SCOPUS:84876964317

VL - 8

SP - 239

EP - 246

JO - Expert Review of Endocrinology and Metabolism

JF - Expert Review of Endocrinology and Metabolism

SN - 1744-6651

IS - 3

ER -